enGene Holdings Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for enGene Holdings Inc. (ENGN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Oct 2024Oct 2023Oct 2022Oct 2021
Operating Activities
Net Income-117.30-55.14-99.92-24.46-23.44
Depreciation & Amortization-2.560.320.180.240.27
Stock Based Compensation9.655.323.450.120.44
Change in Working Capital9.740.100.492.17-1.04
Change in Accounts Receivable-0.600.000.000.000.00
Change in Accounts Payable4.940.470.37-0.200.11
Change in Other Working Capital5.390.971.702.23-1.44
Other Operating Activities1.240.9774.024.347.79
Net Cash from Operating Activities-99.24-48.28-24.74-17.59-15.98
Investing Activities
Capital Expenditures-1.49-0.930.32-0.15-0.25
Purchases of Investments-160.84-125.030.000.000.00
Sales/Maturities of Investments137.19-125.030.000.000.00
Net Cash from Investing Activities-25.14-125.95-0.32-0.15-0.25
Financing Activities
Debt Repayment-0.70-9.45-3.18-1.010.00
Common Stock Issued2.22260.1556.890.010.01
Other Financing Activities0.00-13.58-5.61-0.44-0.14
Net Cash from Financing Activities1.52265.7286.1527.9722.53
Summary
Effect of Forex Changes on Cash0.000.000.00-0.810.00
Net Change in Cash-122.8591.4861.099.426.39
Cash at Beginning of Period173.0081.5220.4311.020.00
Cash at End of Period50.15173.0020.4320.430.00
Free Cash Flow-100.72-49.21-25.06-17.75-16.23
Supplemental Disclosures
Interest Paid2.291.931.400.620.00